New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 29, 2014
08:03 EDTSTAASTAAR Surgical has upside potential following solid yearly start, says Canaccord
Canaccord remains bullish on STAAR Surgical citing its solid start to 2014 and sum of the parts methodology. The firm sees a number of catalysts including gross margin expansion, revenue growth acceleration, and potential for raised guidance. Shares are Buy rated and price target increased to $21 from $20.
News For STAA From The Last 14 Days
Check below for free stories on STAA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 1, 2014
08:45 EDTSTAASTAAR Surgical price target lowered to $16 from $21 at Canaccord
Subscribe for More Information
July 31, 2014
16:32 EDTSTAASTAAR Surgical backs 2014 revenue growth view 8%-10%, consensus $80.33M
Subscribe for More Information
16:29 EDTSTAASTAAR Surgical reports Q2 adjusted EPS 1c, consensus 3c
Reports Q2 revenue $20M, consensus $19.81M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use